Related references
Note: Only part of the references are listed.Races of small molecule clinical trials for the treatment of COVID-19: An up-to-date comprehensive review
Suwen Hu et al.
DRUG DEVELOPMENT RESEARCH (2022)
Synthesis and characterization of 1,2,4-triazolo[1,5-a]pyrimidine-2-carboxamide-based compounds targeting the PA-PB1 interface of influenza A virus polymerase
Serena Massari et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Indomethacin-based PROTACs as pan-coronavirus antiviral agents
Jenny Desantis et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Perspectives on SARS-CoV-2 Main Protease Inhibitors
Kaifu Gao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
The antifungal drug isavuconazole inhibits the replication of human cytomegalovirus (HCMV) and acts synergistically with anti-HCMV drugs
Beatrice Mercorelli et al.
ANTIVIRAL RESEARCH (2021)
The SARS-CoV-2 main protease Mpro causes microvascular brain pathology by cleaving NEMO in brain endothelial cells
Jan Wenzel et al.
NATURE NEUROSCIENCE (2021)
Mechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CLpro substrate degradome
Isabel Pablos et al.
CELL REPORTS (2021)
Hepatitis C virus drugs that inhibit SARS-CoV-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture
Khushboo Bafna et al.
CELL REPORTS (2021)
Anti-MRSA drug discovery by ligand-based virtual screening and biological evaluation
Xu Lian et al.
BIOORGANIC CHEMISTRY (2021)
Inhibitor potency and assay conditions: A case study on SARS-CoV-2 main protease
Mira A. M. Behnam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
Linlin Zhang et al.
SCIENCE (2020)
Structure-Based Virtual Screening: From Classical to Artificial Intelligence
Eduardo Habib Bechelane Maia et al.
FRONTIERS IN CHEMISTRY (2020)
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Zhenming Jin et al.
NATURE (2020)
Merging Ligand-Based and Structure-Based Methods in Drug Discovery: An Overview of Combined Virtual Screening Approaches
Javier Vazquez et al.
MOLECULES (2020)
Conserved interactions required for inhibition of the main protease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Alina Shitrit et al.
SCIENTIFIC REPORTS (2020)
Recent Progress in the Drug Development Targeting SARS-CoV-2 Main Protease as Treatment for COVID-19
Wen Cui et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
Potent and broad-spectrum cycloheptathiophene-3-carboxamide compounds that target the PA-PB1 interaction of influenza virus RNA polymerase and possess a high barrier to drug resistance
Giulio Nannetti et al.
ANTIVIRAL RESEARCH (2019)
Exploring the cycloheptathiophene-3-carboxamide scaffold to disrupt the interactions of the influenza polymerase subunits and obtain potent anti-influenza activity
Jenny Desantis et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Detecting similar binding pockets to enable systems polypharmacology
Miguel Duran-Frigola et al.
PLOS COMPUTATIONAL BIOLOGY (2017)
Comparing Drug Images and Repurposing Drugs with BioGPS and FLAPdock: The Thymidylate Synthase Case
Lydia Siragusa et al.
CHEMMEDCHEM (2016)
Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
Shuo Su et al.
TRENDS IN MICROBIOLOGY (2016)
A Rational Approach for the Identification of Non-Hydroxamate HDAC6-Selective Inhibitors
Laura Goracci et al.
SCIENTIFIC REPORTS (2016)
Drug Repurposing Approach Identifies Inhibitors of the Prototypic Viral Transcription Factor IE2 that Block Human Cytomegalovirus Replication
Beatrice Mercorelli et al.
CELL CHEMICAL BIOLOGY (2016)
Pharmacophore-based discovery of inhibitors of a novel drug/proton antiporter in human brain endothelial hCMEC/D3 cell line
Helene Chapy et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
A Broad Anti-influenza Hybrid Small Molecule That Potently Disrupts the Interaction of Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Subunits
Serena Massari et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
BioGPS: Navigating biological space to predict polypharmacology, off-targeting, and selectivity
Lydia Siragusa et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2015)
Pharmacophore modeling technique applied for the discovery of proteasome inhibitors
Chiara Pautasso et al.
EXPERT OPINION ON DRUG DISCOVERY (2014)
Optimization of Small-Molecule Inhibitors of Influenza Virus Polymerase: From Thiophene-3-Carboxamide to Polyamido Scaffolds
Susan Lepri et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Structural Investigation of Cycloheptathiophene-3-carboxamide Derivatives Targeting Influenza Virus Polymerase Assembly
Serena Massari et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Human Cytomegalovirus Inhibitor AL18 Also Possesses Activity against Influenza A and B Viruses
Giulia Muratore et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
PoSSuM: a database of similar protein-ligand binding and putative pockets
Jun-Ichi Ito et al.
NUCLEIC ACIDS RESEARCH (2012)
Small molecule inhibitors of influenza A and B viruses that act by disrupting subunit interactions of the viral polymerase
Giulia Muratore et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
FragVLib a free database mining software for generating Fragment-based Virtual Library using pocket similarity search of ligand-receptor complexes
Raed Khashan
JOURNAL OF CHEMINFORMATICS (2012)
A common reference framework for analyzing/comparing proteins and ligands. Fingerprints for ligands and proteins (FLAP): Theory and application
Massimo Baroni et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2007)
Hydrogen bonding interactions of covalently bonded fluorine atoms: From crystallographic data to a new angular function in the GRID force field
E Carosati et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Target selection in drug discovery
J Knowles et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Share Paper
